QLT Revenue and Competitors
Estimated Revenue & Valuation
- QLT's estimated annual revenue is currently $17.8M per year.
- QLT's estimated revenue per employee is $155,000
Employee Data
- QLT has 115 Employees.
- QLT grew their employee count by 7% last year.
QLT's People
| Name | Title | Email/Phone |
|---|
QLT Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $70.4M | 255 | 5% | N/A | N/A |
What Is QLT?
QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the company is publicly traded on NASDAQ (symbol: QLTI) and the Toronto Stock Exchange (symbol: QLT). For more information, visit our website at www.qltinc.com.
keywords:N/A
N/A
Total Funding
115
Number of Employees
$17.8M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
QLT News
Alkermes; Genentech; Bend Research; QLT; Endocyte; BIND Biosciences; UCB Group (UCB); Presage Bioscience; Polymer Factory; MicroCHIPS...
QLT has been the topic of several other reports. JPMorgan Chase & Co. cut their price objective on shares of Quilter from GBX 200 ($2.61) to...
QLT has been the subject of several other research reports. Barclays reiterated an underweight rating and issued a GBX 120 ($1.56) price...
Other Companies in Vancouver
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $25.3M | 115 | 8% | N/A |
#2 | $33.4M | 115 | 11% | N/A |
#3 | $15M | 115 | -7% | N/A |
#4 | $7.5M | 115 | 6% | N/A |
#5 | $16.7M | 115 | 10% | N/A |